The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
We expect our cash flow to improve, and we continue to believe that we will not require a placing of shares, unless it is for strategic acquisition and growth purposes.
We continue to advance our buy and build strategy to ensure continued and substantive ongoing growth of the business. We continue to be presented with and review potential acquisitions that are both complementary and supplementary to its existing businesses which will further enhance free cash flow and move us close to executing the 2B plan.
Nice buy after time, things are slowly starting to look up. Maybe Gobind was right all along with his approach to comms, maybe they are getting noticed in the right circles.....Can't be much free float left hanging about, as we know, when it moves it moves fast.
Indeed, more to come. Patience is the key & before you start bleating on about "It's been years & where's the shareholder value etc etc" look at what has been achieved over the years, obviously far to much for you to comprehend so all you do is bleat on about how long it's taking. Do you still actually own any of this stock or sold out? Do your children still own this stock or sold out?
It's operating the way it was structured to do...put simply...people pay in & people withdraw cash when they've made some profit. Think of it as a 7.2% high interest account.
If you do some in depth research you'll find the small caps market was down 30% last year, this was probably due to several factors that are still with us. It's tough out there but 7.2% return on an investment is a win in my eyes, over double what the high Street is offering.
It's starting to get interesting now, maybe the new broker is having an effect (who knows) Hopefully they stay in sticky hands which means the ever dwindling free float is diminishing even further. My gut feeling is there is plenty to come.
Good solid week with not a lot of selling, more stock going into sticky hands, which in turn reduces the free float, which, as we've all seen moves the sp quickly, hopefully we'll see the same again next week as the buyer continues to accumulate, meanwhile in the background the team are working hard & the wheels are turning generating revenues. Plenty to come, including a few surprises of which I'm sure.
Valuation The shares appear materially behind events. They are only marginally up during a two year period which saw a 70x increase in AUM and strong progress against the strategic plan. We
put fair value well above (arguably a multiple of) the current price based solely on what’s been
achieved so far